CREDIT SUISSE AG/ - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 155 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2022$0
-100.0%
12
-100.0%
0.00%
Q1 2022$198,000
-37.9%
303,297
+3.7%
0.00%
Q4 2021$319,000
+27.6%
292,518
+112.4%
0.00%
Q3 2021$250,000
-27.5%
137,750
+5.5%
0.00%
Q2 2021$345,000
-39.9%
130,514
-18.2%
0.00%
Q1 2021$574,000
-27.4%
159,494
-49.2%
0.00%
Q4 2020$791,000
-3.8%
314,210
-3.7%
0.00%
-100.0%
Q3 2020$822,000
-18.7%
326,123
+5.8%
0.00%0.0%
Q2 2020$1,011,000
+81.8%
308,218
+35.8%
0.00%
Q1 2020$556,000
-41.9%
227,028
+11.8%
0.00%
-100.0%
Q4 2019$957,000
+10.4%
203,031
+0.2%
0.00%0.0%
Q3 2019$867,000
+46.7%
202,603
+99.9%
0.00%0.0%
Q2 2019$591,000
+70.8%
101,375
+12.4%
0.00%
Q1 2019$346,000
+111.0%
90,203
+2.6%
0.00%
Q4 2018$164,000
-30.8%
87,898
+18.7%
0.00%
Q3 2018$237,000
-29.9%
74,079
-33.7%
0.00%
Q2 2018$338,000
-35.9%
111,723
-17.0%
0.00%
Q1 2018$527,000
+22.0%
134,561
+29.0%
0.00%
Q4 2017$432,000
-57.3%
104,316
-36.7%
0.00%
-100.0%
Q3 2017$1,011,000
+33.9%
164,773
+35.8%
0.00%0.0%
Q2 2017$755,000
-34.8%
121,326
-33.6%
0.00%0.0%
Q1 2017$1,158,000
+51.2%
182,699
+27.7%
0.00%0.0%
Q4 2016$766,000
+29.2%
143,102
+35.9%
0.00%0.0%
Q3 2016$593,000
-5.0%
105,290
-7.4%
0.00%0.0%
Q2 2016$624,000
-58.0%
113,679
-43.1%
0.00%
-50.0%
Q1 2016$1,484,000
+10.7%
199,825
+23.9%
0.00%0.0%
Q4 2015$1,340,000
-74.9%
161,281
-72.8%
0.00%
-71.4%
Q3 2015$5,343,000
+103.2%
592,838
+170.5%
0.01%
+133.3%
Q2 2015$2,630,000
+254.0%
219,173
+217.9%
0.00%
+200.0%
Q1 2015$743,000
+324.6%
68,940
+100.3%
0.00%
Q4 2014$175,000
-8.4%
34,424
-52.7%
0.00%
Q3 2014$191,000
-46.6%
72,781
-17.8%
0.00%
Q2 2014$358,000
-35.5%
88,567
-27.0%
0.00%
-100.0%
Q1 2014$555,000
+55.0%
121,287
+47.3%
0.00%
Q4 2013$358,000
+173.3%
82,365
+147.9%
0.00%
Q3 2013$131,000
+28.4%
33,230
-31.1%
0.00%
Q2 2013$102,000
-46.6%
48,262
-53.8%
0.00%
Q1 2013$191,000104,4530.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
Third Security, LLC 17,815,708$47,033,0002.93%
Essex Woodlands Management, Inc. 2,764,908$7,130,0002.60%
Belmont Global Advisors, Inc. 973,000$2,569,0002.01%
Belmont Global Advisors, Inc. 135,700$358,0000.28%
MSD Partners, L.P. 2,750,000$7,260,0000.22%
SFMG, LLC 99,850$264,0000.08%
Rotella Capital Management, Inc. 11,090$29,0000.03%
WESTPORT RESOURCES MANAGEMENT INC 33,500$88,0000.02%
SMITH ASSET MANAGEMENT GROUP LP 236,590$625,0000.02%
FRANKLIN STREET ADVISORS INC /NC 41,150$109,0000.02%
View complete list of ZIOPHARM ONCOLOGY INC shareholders